Research-grade compound. Laboratory use only. Not intended for human or animal use, ingestion, or injection. No medical claims are made or implied.
≥98% PurityIn-House HPLC & MS Tested
GLP-1 and Incretin Research PeptidesSKU: CP-SL100
SLU-PP-332 Capsule 100mg
≥99% PurityHPLC & MS verified
€343.99Out of Stock
Delivers to EU in 7-10 business days
Free shipping over €200 · no customs paperwork (EU) · via EU carrier network
Research-grade SLU-PP-332 Capsule. 99.3% avg purity, HPLC & MS verified. Oral capsules in sealed bottle. For laboratory research use only. Not for human consumption.
📦
MADE TO ORDER — Expected delivery: ~3 weeks
Synthesized after your order is placed. We'll email you tracking details when it ships.
Currently Unavailable38 researchers waiting
This product is being restocked
We're working with our supplier to restock this item. Sign up below to be the first to know, or save it to your wishlist.
Important Notice
This product is intended for laboratory and research use only. Not for human or veterinary use. By purchasing, you confirm this product will be used exclusively for in-vitro research purposes.
When This Product May Not Suit Your Research
- ⚠If your research requires GMP-grade material for clinical applications — research-grade peptides are not intended for clinical use.
- ⚠If your lab lacks proper cold storage (-20°C freezer) — this peptide's stability may be compromised at higher temperatures.
- ⚠If your study protocol requires FDA-approved reference standards — contact USP or a certified reference material provider.
Purity HPLC
99.3% average HPLC purity, verified by independent third-party testing
Third-Party Tested
Janoshik report published when available
Fast Shipping
24h dispatch, EU-wide shipping from €4.99
Third-Party Tested
Independent lab verification for every batch
Last reviewed: 2026-04-05
About SLU-PP-332 Capsule 100mg
SLU-PP-332 Capsule provides 100mg of the ERRalpha/ERRgamma nuclear receptor agonist in a pre-dosed oral format. Unlike peptide products that face GI degradation challenges, SLU-PP-332 is a small molecule (MW 490.6 Da) with oral bioavailability -- the capsule format is a convenience for researchers who need standardized dosing units rather than weighing powder for each protocol. This simplifies chronic oral administration studies in animal models.
ERR (estrogen-related receptor) nuclear receptors regulate mitochondrial biogenesis, oxidative metabolism, and fatty acid oxidation. SLU-PP-332 was developed at Saint Louis University as a selective pharmacological tool for this pathway, which had been difficult to study due to a lack of potent selective agonists. The "exercise mimetic" framing comes from what ERR activation does: it drives many of the same transcriptional programs as endurance exercise -- PGC-1alpha-dependent mitochondrial biogenesis, increased oxidative enzyme expression, and fiber type shifts toward slow-twitch oxidative phenotypes.
Chronic oral dosing studies -- which capsule format facilitates -- address questions about metabolic adaptation over time: does sustained ERR activation produce lasting changes in mitochondrial density, metabolic flexibility, or exercise tolerance? These time-course experiments are harder to design with compounds requiring daily reconstitution, which is where the capsule format adds real value for chronic protocol design.
Research Applications
SLU-PP-332 is used in research on mitochondrial biogenesis, exercise physiology and metabolic adaptation, ERR nuclear receptor pharmacology, obesity and metabolic syndrome models, and cardiovascular function. The capsule format is specifically suited for chronic oral dosing studies.
Specifications
| Parameter | Value |
|---|---|
| Active Ingredient | SLU-PP-332 (ERRalpha/ERRgamma agonist) |
| Dose per Capsule | 100mg |
| Molecular Weight | 490.6 Da |
| Purity | 99.3% avg (HPLC verified) |
| Format | Oral capsule |
| Storage | Room temperature, protect from moisture |
Storage
Store at room temperature in a dry place. SLU-PP-332 is a small molecule with good stability -- no special cold storage required for short-term use. Protect from excessive moisture and light.
What are ERRalpha and ERRgamma receptors?
Estrogen-related receptors (ERRs) are a subfamily of orphan nuclear receptors -- "orphan" because they lack identified endogenous ligands. ERRalpha and ERRgamma are particularly important for regulating mitochondrial gene expression, fatty acid oxidation, and oxidative phosphorylation. They work closely with the PGC-1 family of transcriptional coactivators to drive the mitochondrial biogenesis response. SLU-PP-332 activates both isoforms, making it useful for studying ERR-driven metabolic programs without needing to manipulate ERR expression genetically.
How does SLU-PP-332 differ from SR9009 as an exercise mimetic?
Both compounds engage metabolic adaptation pathways activated by endurance exercise, but through different mechanisms. SR9009 targets Rev-Erbalpha (a circadian clock nuclear receptor), while SLU-PP-332 targets ERRalpha/ERRgamma. These are distinct pathways that converge on overlapping but not identical metabolic programs. Having both compounds available allows researchers to determine which metabolic effects are pathway-specific versus common to ERR and Rev-Erb activation. SLU-PP-332 also has oral bioavailability, which SR9009 lacks in rat models.
Why is the capsule format useful for this compound specifically?
SLU-PP-332's oral bioavailability makes the capsule format functionally useful rather than merely convenient. For studying mitochondrial biogenesis and metabolic adaptation, chronic dosing studies are more informative than acute experiments -- it takes time for mitochondrial density to change measurably. The capsule format standardizes each dose, simplifies daily administration in animal models, and reduces protocol variability compared to weighing powder for each dosing event.
SLU-PP-332 Capsule is supplied for laboratory research use only. Not approved for human use. Handle in compliance with institutional biosafety guidelines.
Specification Summary
Purity99.3% avg
FormLyophilized Powder
Storage-20\u00B0C
Researcher Confidence
Why researchers choose CertaPeptides
Who actually tests this?
Every batch is independently verified by Janoshik Analytical (100,000+ verifications/month), Eurofins Scientific, and Analytical Sciences International. We publish every Certificate of Analysis.
View COAs →What if I get the wrong batch?
Every bottle label carries a lot number that maps to a specific Certificate of Analysis. If a batch fails spec, we don't ship it — full stop.
View COAs →Where does it ship from?
Romania (EU). We are CERTALAB SRL, CUI RO54451735, VAT-registered. SameDay for Romania, FanCourier for Central/Eastern EU, TCE Worldwide for the rest. 3–7 business days EU-wide.
Shipping details →What if there's a problem?
You have a 14-day withdrawal right under OUG 34/2014 (Romanian/EU consumer law), with ANPC/ODR escalation available. Contact us at support@certapeptides.com.
Returns policy →Product Information
This product is intended for scientific research and development purposes only. It is a chemical substance that shall not be used as a drug, medicine, active substance, or ingredient in any product intended for human or animal consumption. Researchers must handle this compound in accordance with their institutional biosafety guidelines. Use only in properly equipped laboratory settings with appropriate personal protective equipment.
Frequently Asked
Research Library
Related Research Articles
Based on category & popularity
Researchers Also Studied
500mcgSAME FIELDGLP-1 and Incretin Research Peptides
KPV Oral Capsules 500mcg
KPV is a naturally occurring tripeptide (Lys-Pro-Val) derived from the C-terminal end of alpha-melanocyte-stimulating hormone (alpha-MSH). It has been studied for its immunomodulatory signaling in gastrointestinal and immune biology research models. Alpha-MSH-derived immunomodulatory tripeptide Intestinal epithelial barrier and PepT1 transporter research NF-kB pathway modulation studies For research purposes only. Not for human consumption.
€257.99
SAME FIELDGLP-1 and Incretin Research Peptides
Semaglutide Oral Capsules
Oral Semaglutide capsules for research into GLP-1 receptor agonism via enteric delivery. Available in 3mg and 7mg formulations. Supplied at 99.3% avg purity (HPLC-verified), with a Certificate of Analysis for every batch. Key research areas: Oral peptide bioavailability and absorption kinetics GLP-1 receptor-mediated glucose homeostasis Enteric coating and SNAC co-formulation studies For research purposes only. Not for human consumption.
From€171.99
RESEARCHERS ALSO STUDIEDBundles
Retatrutide Research Starter Kit
Retatrutide 10mg + Bacteriostatic Water 5ml + syringe + storage vial + alcohol pads. Everything you need to begin research. For research purposes only.
€NaN
RESEARCHERS ALSO STUDIEDBundles
Tirzepatide Research Starter Kit
Tirzepatide 10mg + Bacteriostatic Water 5ml + syringe + storage vial + alcohol pads. Everything you need to begin research. For research purposes only.
€NaN